<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39325308</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2198-7793</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Surgical case reports</Title><ISOAbbreviation>Surg Case Rep</ISOAbbreviation></Journal><ArticleTitle>Rectum necrosis in a patient with severe COVID19 infection after CAR-T therapy: a case report.</ArticleTitle><Pagination><StartPage>227</StartPage><MedlinePgn>227</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">227</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40792-024-02026-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Coronavirus disease 2019 (COVID19) can cause gastrointestinal complications as well as respiratory tract disease. Coagulation abnormalities and thrombosis frequently occur in COVID19, especially in cases with severe clinical outcome. The relationship between gastrointestinal perforation and coagulopathy due to COVID19 remains unclear.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A 49-year-old female received Chimeric antigen receptor T (CAR-T) therapy for an early recurrence of diffuse large B-cell lymphoma (DLBCL) that was refractory to chemotherapy. She was diagnosed with cytokine release syndrome (CRS) because of a fever and oxygen desaturation, and administered tocilizumab. Forty days after completing CAR-T therapy, she was infected with COVID19 and transferred to our hospital. Her general condition worsened and she developed COVID19 pneumonia, and then steroid pulse therapy was started. While her respiratory condition improved, she experienced pain in the anal region and computed tomography (CT) revealed a rectal perforation. An emergency surgery was undertaken, and the lower rectum wall was found to be completely necrotic. Removal of the necrotic part of the rectum tissue, and drainage and lavage of necrotic tissue in the pelvic cavity were performed. The remaining rectum was resected with partial sigmoidectomy, but we could not make the anal stump closed. In addition, an end colostomy in the sigmoid colon was performed. Histopathological findings showed thromboses in the rectal mesentery veins. After the first surgery, the pelvic abscess cavity persisted and her high-grade fever continued. Reoperation was laparoscopically performed, and she underwent a resection of anal canal with residual necrotic rectal and mesorectal tissue, and a drainage of the pelvic abscess. After the reoperation, her general condition improved and CT showed that the abscess cavity had significantly improved.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Gastrointestinal perforation, especially rectal necrosis due to coagulopathy caused by severe COVID19 infection, is a rare but life-threatening complication. Physicians should have a high degree of clinical suspicion for timely diagnosis and management, and surgical intervention is necessary in cases of rectal necrosis.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saeki</LastName><ForeName>Kiyoshi</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-1214-3215</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Hamanomachi General Hospital, 3-3-1, Nagahama, Fukuoka, 810-8539, Japan. saeki.med@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nakagama</LastName><ForeName>Hidenobu</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hamanomachi General Hospital, 3-3-1, Nagahama, Fukuoka, 810-8539, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tanaka</LastName><ForeName>Yuichi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hamanomachi General Hospital, 3-3-1, Nagahama, Fukuoka, 810-8539, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Goto</LastName><ForeName>Yoshitaka</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hamanomachi General Hospital, 3-3-1, Nagahama, Fukuoka, 810-8539, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaneshiro</LastName><ForeName>Kazuhisa</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hamanomachi General Hospital, 3-3-1, Nagahama, Fukuoka, 810-8539, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kono</LastName><ForeName>Hiroshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hamanomachi General Hospital, 3-3-1, Nagahama, Fukuoka, 810-8539, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yanai</LastName><ForeName>Kosuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hamanomachi General Hospital, 3-3-1, Nagahama, Fukuoka, 810-8539, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamamoto</LastName><ForeName>Hirofumi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hamanomachi General Hospital, 3-3-1, Nagahama, Fukuoka, 810-8539, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoneda</LastName><ForeName>Reiko</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pathology, Hamanomachi General Hospital, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimakawa</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Hematology, Hamanomachi General Hospital, Fukuoka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ueki</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Surgery, Hamanomachi General Hospital, 3-3-1, Nagahama, Fukuoka, 810-8539, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Surg Case Rep</MedlineTA><NlmUniqueID>101662125</NlmUniqueID><ISSNLinking>2198-7793</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID19</Keyword><Keyword MajorTopicYN="N">Coagulopathy</Keyword><Keyword MajorTopicYN="N">Emergency surgery</Keyword><Keyword MajorTopicYN="N">Rectum necrosis</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>12</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>11</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39325308</ArticleId><ArticleId IdType="pmc">PMC11427651</ArticleId><ArticleId IdType="doi">10.1186/s40792-024-02026-1</ArticleId><ArticleId IdType="pii">10.1186/s40792-024-02026-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(7):667–78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7217643</ArticleId><ArticleId IdType="pubmed">32405603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bulte JP, Postma N, Beukema M, Inberg B, Stegeman AG, van der Hoeven H. COVID 19 and the risk of gastro-intestinal perforation: a case series and literature review. J Crit Care. 2022;67:100–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8562067</ArticleId><ArticleId IdType="pubmed">34741961</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhry B, Alekseyev K, Didenko L, Chaudhry M. A case of abdominal perforation in a COVID+ patient treated with tocilizumab and corticosteroids. Clin Med Insights Case Rep. 2023;16:11795476231173870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10278419</ArticleId><ArticleId IdType="pubmed">37342097</ArticleId></ArticleIdList></Reference><Reference><Citation>Gartland RM, Velmahos GC. Bowel necrosis in the setting of COVID-19. J Gastrointest Surg. 2020;24(12):2888–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196179</ArticleId><ArticleId IdType="pubmed">32363540</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiwango F, Mremi A, Masenga A, Akrabi H. Intestinal ischemia in a COVID-19 patient: case report from Northern Tanzania. J Surg Case Rep. 2021;2021(1):rjaa537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7837360</ArticleId><ArticleId IdType="pubmed">33532049</ArticleId></ArticleIdList></Reference><Reference><Citation>Kono J, Yoshimaru K, Matsuura T, Tamaki A, Takemoto J, Matsumoto S, et al. COVID19 detection in appendix of acute appendicitis in a child: a case report and review of literature. Surg Case Rep. 2023;9(1):37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10012291</ArticleId><ArticleId IdType="pubmed">36917284</ArticleId></ArticleIdList></Reference><Reference><Citation>Masanam MK, Cheney SM, Sutton W, Keyloun JW, Fitzgibbons S. COVID-19 infection and large intestinal perforation: a case series. Int J Surg Case Rep. 2022;98: 107538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9395222</ArticleId><ArticleId IdType="pubmed">36027834</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto Y, Yasuda Y, Yamamoto A, Miyauchi Y, Takahashi KI, Ri S. Successful laparoscopic lavage and drainage for intestinal perforation in a patient with COVID-19: a case report. Int J Surg Case Rep. 2022;91: 106792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8785261</ArticleId><ArticleId IdType="pubmed">35086045</ArticleId></ArticleIdList></Reference><Reference><Citation>Morioka H, Goto M, Tanaka H, Momose H, Fujino K, Hagiwara T, et al. Acute intestinal necrosis due to multiple thrombosis in COVID-19 patient. Report of a case. Surg Case Rep. 2022;8(1):136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9295081</ArticleId><ArticleId IdType="pubmed">35852719</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahas SC, Meira JJD, Sobrado LF, Sorbello M, Segatelli V, Abdala E, et al. Intestinal perforation caused by Covid-19. Arq Bras Cir Dig. 2020;33(2): e1515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682143</ArticleId><ArticleId IdType="pubmed">33237160</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatsutsumi K, Endo A, Okuzawa H, Onishi I, Koyanagi A, Nagaoka E, et al. Colon perforation as a complication of COVID-19: a case report. Surg Case Rep. 2021;7(1):175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8334329</ArticleId><ArticleId IdType="pubmed">34347185</ArticleId></ArticleIdList></Reference><Reference><Citation>Westin J, Sehn LH. CAR T cells as a second-line therapy for large B-cell lymphoma: a paradigm shift? Blood. 2022;139(18):2737–46.</Citation><ArticleIdList><ArticleId IdType="pubmed">35240677</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakouny Z, Labaki C, Grover P, Awosika J, Gulati S, Hsu CY, et al. Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19. JAMA Oncol. 2023;9(1):128–34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9634600</ArticleId><ArticleId IdType="pubmed">36326731</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T, Warkentin TE, Thachil J, Levi M, Levy JH. Proposal of the definition for COVID-19-associated coagulopathy. J Clin Med. 2021;10(2):191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7827226</ArticleId><ArticleId IdType="pubmed">33430431</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, et al. Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL. Cancer Sci. 2023;114(6):2689–91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10236623</ArticleId><ArticleId IdType="pubmed">36929591</ArticleId></ArticleIdList></Reference><Reference><Citation>Majer A, Kenig J. Idiopathic rectal necrosis in 72-year-old women: report of a case and a literature review. Folia Med Cracov. 2014;54(2):47–54.</Citation><ArticleIdList><ArticleId IdType="pubmed">25648309</ArticleId></ArticleIdList></Reference><Reference><Citation>Maun D, Silverberg D, Steinhagen RM. Acute ischemic proctitis: report of four cases. Dis Colon Rectum. 2007;50(7):1082–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17160570</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassif M, Ameer A, Meterissian SH, Meguerditchian AN. A case of unresectable rectal necrosis. Case Rep Med. 2011;2011: 212840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3099196</ArticleId><ArticleId IdType="pubmed">21629852</ArticleId></ArticleIdList></Reference><Reference><Citation>Azimuddin K, Raphaeli T. Acute ischemic gangrene of the rectum: report of 3 cases and review of literature. Int J Surg Case Rep. 2013;4(12):1120–3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3860038</ArticleId><ArticleId IdType="pubmed">24240084</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B, Mechineni A, Kaur P, Ajdir N, Maroules M, Shamoon F, et al. Acute intestinal ischemia in a patient with COVID-19 infection. Korean J Gastroenterol. 2020;76(3):164–6.</Citation><ArticleIdList><ArticleId IdType="pubmed">32969365</ArticleId></ArticleIdList></Reference><Reference><Citation>Deepak Verma SS, Garg LK, Tinaikar A. Gastrointestinal perforation in COVID-19 patients—case series and review of the literature. Clin Surg Res Commun. 2020;4(4):13–7.</Citation></Reference><Reference><Citation>Giuffre M, Bozzato AM, Di Bella S, Occhipinti AA, Martingano P, Cavallaro MFM, et al. Spontaneous rectal perforation in a patient with SARS-CoV-2 infection. J Pers Med. 2020;10(4):157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7712943</ArticleId><ArticleId IdType="pubmed">33049924</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuffre M, Di Bella S, Sambataro G, Zerbato V, Cavallaro M, Occhipinti AA, et al. COVID-19-induced thrombosis in patients without gastrointestinal symptoms and elevated fecal calprotectin: hypothesis regarding mechanism of intestinal damage associated with COVID-19. Trop Med Infect Dis. 2020;5(3):147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7557761</ArticleId><ArticleId IdType="pubmed">32947803</ArticleId></ArticleIdList></Reference><Reference><Citation>Fisher L, Amital H, Goitein O. Superior mesenteric vein thrombosis in an adult patient. Isr Med Assoc J. 2022;24(11):773–4.</Citation><ArticleIdList><ArticleId IdType="pubmed">36436048</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J, Berger JS. Thrombosis in hospitalized patients with COVID-19 in a New York City Health System. JAMA. 2020;324(8):799–801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7372509</ArticleId><ArticleId IdType="pubmed">32702090</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438–40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Amaravathi U, Balamurugan N, Muthu Pillai V, Ayyan SM. Superior mesenteric arterial and venous thrombosis in COVID-19. J Emerg Med. 2021;60(5):e103–7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833911</ArticleId><ArticleId IdType="pubmed">33581991</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeilani M, Hill R, Riad M, Abdulaal Y. Superior mesenteric vein and portal vein thrombosis in a patient with COVID-19: a rare case. BMJ Case Rep. 2021;14(6):e244049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8220528</ArticleId><ArticleId IdType="pubmed">34158339</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee DW, Gardner R, Porter DL, Louis CU, Ahmed N, Jensen M, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124(2):188–95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4093680</ArticleId><ArticleId IdType="pubmed">24876563</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart AG, Henden AS. Infectious complications of CAR T-cell therapy: a clinical update. Ther Adv Infect Dis. 2021;8:20499361211036772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8388233</ArticleId><ArticleId IdType="pubmed">34457269</ArticleId></ArticleIdList></Reference><Reference><Citation>Santomasso BD, Nastoupil LJ, Adkins S, Lacchetti C, Schneider BJ, Anadkat M, et al. Management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy: ASCO guideline. J Clin Oncol. 2021;39(35):3978–92.</Citation><ArticleIdList><ArticleId IdType="pubmed">34724386</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotch C, Barrett D, Teachey DT. Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome. Expert Rev Clin Immunol. 2019;15(8):813–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7936577</ArticleId><ArticleId IdType="pubmed">31219357</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F, et al. Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020;19(7): 102568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7252115</ArticleId><ArticleId IdType="pubmed">32376398</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Li L, Shen A, Chen Y, Qi Z. Rational use of tocilizumab in the treatment of novel coronavirus pneumonia. Clin Drug Investig. 2020;40(6):511–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7183818</ArticleId><ArticleId IdType="pubmed">32337664</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad E, Awadelkarim A, Agab M, Babkir A. Tocilizumab-associated small bowel perforation in a young patient with rheumatoid arthritis: a lesson to remember during COVID-19 pandemic. J Med Cases. 2022;13(3):135–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8929210</ArticleId><ArticleId IdType="pubmed">35356392</ArticleId></ArticleIdList></Reference><Reference><Citation>Strangfeld A, Richter A, Siegmund B, Herzer P, Rockwitz K, Demary W, et al. Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs. Ann Rheum Dis. 2017;76(3):504–10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5445993</ArticleId><ArticleId IdType="pubmed">27405509</ArticleId></ArticleIdList></Reference><Reference><Citation>Jagpal A, Curtis JR. Gastrointestinal perforations with biologics in patients with rheumatoid arthritis: implications for clinicians. Drug Saf. 2018;41(6):545–53.</Citation><ArticleIdList><ArticleId IdType="pubmed">29392593</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwab K, Hamidi S, Chung A, Lim RJ, Khanlou N, Hoesterey D, et al. Occult colonic perforation in a patient with coronavirus disease 2019 after interleukin-6 receptor antagonist therapy. Open Forum Infect Dis. 2020;7(11):ofaa424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543619</ArticleId><ArticleId IdType="pubmed">33204749</ArticleId></ArticleIdList></Reference><Reference><Citation>ReMine SG, McIlrath DC. Bowel perforation in steroid-treated patients. Ann Surg. 1980;192(4):581–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1347010</ArticleId><ArticleId IdType="pubmed">7425698</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaxman I, Al Saleh AS, Kumar S, Nitin M, Dispenzieri A, Buadi F, et al. Colon perforation in multiple myeloma patients—a complication of high-dose steroid treatment. Cancer Med. 2020;9(23):8895–901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7724303</ArticleId><ArticleId IdType="pubmed">33022868</ArticleId></ArticleIdList></Reference><Reference><Citation>Narum S, Westergren T, Klemp M. Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open. 2014;4(5): e004587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4025450</ArticleId><ArticleId IdType="pubmed">24833682</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219–29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2903966</ArticleId><ArticleId IdType="pubmed">20139336</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>